AQUAX REPELLENT- ethyl butylacetylaminopropionate cream 
Pella Pharmaceuticals Co. Ltd

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Repellent

Forms and presentation

Cream: Tube of 75 g.

Active Ingredient

Ethyl Butylacetylaminopropionate

Inactive Ingredients

Aqua, Cetearyl Alcohol, Ceteareth-22, Petrolatum, Ceteareth-25, Glycerin, Polysorbate 80, Bis-PEG/ PPG-16/16 PEG/ PPG 16/16 Dimethicone; Caprylic/Capric Triglyceride, Sodium Phosphate, Disodium Phosphate, Methylparaben, Propylparaben and BHA.

Purpose

Insect repellent

Properties

Aquax ® Repellent Cream is a cream that hydrates, nourishes, and expels the pesky insects.

Indications

Aquax ® Repellent Cream hydrates the skin, decreases itchy sensation and provides the feeling of comfort. It's characterized by the presence of the active ingredient Ethyl Butylacetylaminopropionate (IR3535) that acts as a bio-pesticide, its efficacy as insect repellent endures for 6 hours long.

Precautions

Keep out of reach of children

Warnings

Contraindications

Hypersensitivity to any of the components.

Side effects

Aquax ® Repellent Cream has no known side effect, because its use is safe.
Preferably used by small children under the supervision of an adult.

Dosage and administration

Apply just enough Aquax ® Repellent Cream to cover exposed skin.

Storage conditions

Store at a temperature below 30° C.

Primary Package

Primary Package

Secondary Package

Secondary Package

AQUAX REPELLENT 
ethyl butylacetylaminopropionate cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:82160-252
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ETHYL BUTYLACETYLAMINOPROPIONATE (UNII: 65GQA237EH) (ETHYL BUTYLACETYLAMINOPROPIONATE - UNII:65GQA237EH) ETHYL BUTYLACETYLAMINOPROPIONATE75 mg  in 75 g
Inactive Ingredients
Ingredient NameStrength
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
SODIUM PHOSPHATE, MONOBASIC (UNII: 3980JIH2SW)  
SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)  
WATER (UNII: 059QF0KO0R)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
BIS-PEG/PPG-16/16 PEG/PPG-16/16 DIMETHICONE (UNII: 55A74AJ3KB)  
BUTYLATED HYDROXYANISOLE (UNII: REK4960K2U)  
CETEARETH-25 (UNII: 8FA93U5T67)  
GLYCERIN (UNII: PDC6A3C0OX)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
CETEARETH-22 (UNII: 28VZG1E234)  
PETROLATUM (UNII: 4T6H12BN9U)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:82160-252-011 in 1 CARTON10/04/2010
175 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other10/04/2010
Labeler - Pella Pharmaceuticals Co. Ltd (562370925)

Revised: 11/2021
Document Id: d19aeb75-ce57-33ba-e053-2a95a90a5754
Set id: d19aeb75-ce56-33ba-e053-2a95a90a5754
Version: 252
Effective Time: 20211125
 
Pella Pharmaceuticals Co. Ltd